The joint solution enables emerging biotechnology companies to grow successfully by supporting their transition through each stage of the drug development cycle.
Solution Profile
Since 1986, Oracle and IBM have been providing customers with compelling joint solutions, combining the strength of Oracle's relational database leadership and IBM's hardware architecture.
"The IBM and Oracle technology relationship allows our global customers to benefit from joint IBM/Oracle development, technology integration and services collaboration. Oracle products are released on IBM eServer platforms (xSeries, pSeries, zSeries) and TotalStorage and optimized for industry leading performance. Additionally, IBM provides extensive Oracle professional services expertise through IBM Global Services. " - Mike Kerr VP Systems Group Marketing IBM Corporation
The solution combines the Oracle eBusiness Suite with IBM's industry expertise, project management and rapid implementation toolset to provide a cost effective and comprehensive solution for biotechnology companies. The Oracle products include Oracle 9i Database, 9i Application Server, Financials and Purchasing applications.
Distinguishing Features
This solution provides a scalable and reliable toolset for efficiently manage business in the anticipation of continued growth.
The partners listed in the Oracle PartnerNetwork (OPN) Solutions Catalog are part of the Oracle PartnerNetwork Program, however Oracle does not endorse any of the partners or their software, solutions, services or training listed on this site. Oracle disclaims any and all liability arising out of your use of the partners, software, solutions, services and training listed on the site. All software, solutions, services and training are provided “as is” and without warranty, unless provided by the authoring partner.
This solution provides a scalable and reliable toolset for efficiently manage business in the anticipation of continued growth.
